US Stock MarketDetailed Quotes

GNCAQ GENOCEA BIOSCIENCES INC

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Dec 19 16:00 ET
58.78Market Cap0.00P/E (TTM)

About GENOCEA BIOSCIENCES INC Company

Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include GEN-011, an investigational adoptive T cell therapy and GEN-009, a neoantigen cancer vaccine. The company was founded by Robert Paull and Kevin J. Bitterman on August 16, 2006 and is headquartered in Cambridge, MA.

Company Profile

SymbolGNCAQ
Company NameGENOCEA BIOSCIENCES INC
Listing DateFeb 5, 2014
Founded2006
CEOMr. William D. Clark
MarketPink Market
Employees74
Fiscal Year Ends12-31
AddressCambridge Discovery Park,100 Acorn Park Drive,5th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02140
Phone1-617-876-8191
Websitehttp://www.genocea.com

Company Executives

  • Name
  • Position
  • Salary
  • William D. Clark
  • President, Chief Executive Officer and Director
  • --
  • Diantha Duvall
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Jacquelyn L. Sumer
  • Chief Legal and Compliance Officer
  • --
  • Dr. Jessica Baker Flechtner, PhD
  • Chief Scientific Officer
  • --
  • Raymond D. Stapleton, Jr
  • Chief Technology Officer
  • --
  • Girish N. Aakalu
  • Chief Business Officer
  • --
  • Michael J. Higgins
  • Independent Director
  • --
  • Jennifer Lyn Herron
  • Independent Director
  • --
  • Dr. Gisela M. Schwab,M.D.
  • Independent Director
  • --
  • John Lunger
  • Independent Director
  • --
  • Katrine S. Bosley
  • Independent Director
  • --
  • Kenneth M. Bate
  • Independent Director
  • --
  • Dr. George Siber, M.D.
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data